Tibooburra Project Update: RC drilling to commence as Novo forms unincorporated Joint Venture with Manhattan Gold

Novo received all regulatory and landholder approvals for an approximately 2,700 m reverse-circulation drilling program at Tibooburra, NSW, with drilling at the Clone prospect anticipated to begin in early November 2026. The program will test a northern extension of shallowly plunging, high-grade gold mineralisation; Novo’s 2025 drilling returned up to 12 m at 5.90 g/t Au, including 5 m at 13.74 g/t Au. Regional sampling began in September 2026, with results pending and further work underway in October.

Analysis

The approvals remove a practical execution hurdle, not the key valuation uncertainty: whether the shallow high-grade intercept has continuity and enough scale to support a meaningful discovery. The planned step-outs can test that quickly, but a single strong hole is vulnerable to geological variability and does not establish a resource. Accordingly, the likely near-term share-price driver is drill execution and subsequent assays—not the approval itself.

Over the next 1–3 months, a successful extension could improve the market’s view of prospectivity and attract attention to the broader Tibooburra ground position. Conversely, weak or discontinuous results could unwind optimism before regional sampling results have time to generate a new thesis. Any potential 6–18 month value creation depends on repeatable mineralisation, follow-up drilling and a credible path to defining scale; none is established here. Gold-price strength may support exploration sentiment, but it cannot substitute for geological continuity.

The announcement provides no valuation, liquidity, cash runway or funding detail. Those are decisive for sizing: a positive assay catalyst can still be diluted or difficult to monetize if follow-up work requires financing. Treat the company’s schedule and prior results as company-reported until independently corroborated by assay tables and technical disclosure.

Key Decisions for Investors

• No immediate position based solely on approvals. Reassess after confirming the company’s listing/liquidity, cash runway and expected assay-reporting timetable; do not infer a ticker from the name.
• Set a near-term watch for drilling commencement and first assays. A constructive signal would be repeated step-out intersections that demonstrate continuity and geometry, not simply another isolated high-grade result.
• If considering a catalyst trade, keep exposure small and event-sized; avoid adding ahead of assays without clarity on financing and follow-up capacity. A missed start, materially delayed assays or discontinuous results would invalidate the near-term positive setup.
• Monitor regional sampling as a secondary catalyst, not a substitute for drilling evidence. Revisit the thesis over 6–18 months only if follow-up work demonstrates scale and the funding path is credible.